{"product_id":"imizol-ro-85mg-ml-40ml-internal-antiparasite-for-dogs-imidocarb-babesia-canis-ehrlichia-spp","title":"IMIZOL RO 85mg\/ml- 40ML \/\/  INTERNAL ANTIPARASITE FOR DOGS \/\/ Imidocarb \/\/ Babesia canis\/ Ehrlichia spp","description":"\u003cdiv class=\"product_section product_section_description\"\u003e\n\u003cdiv class=\"product_section_content\"\u003e\n\u003cdiv class=\"__i\"\u003e\n\u003cdiv class=\"description\"\u003e\n\u003cp\u003e\u003cspan\u003e\u003cstrong\u003eINTERNAL ANTIPARASITE FOR DOGS IMIZOL 40ML \u003c\/strong\u003e \u003cbr\u003e\u003cbr\u003e\u003cstrong\u003eImizol Ro, 85 mg\/ml\u003c\/strong\u003e injectable solution for dogs.\u003c\/span\u003e\u003cbr\u003e\u003cbr\u003e\u003cspan\u003e\u003cstrong\u003eSTATEMENT OF ACTIVE SUBSTANCES AND OTHER INGREDIENTS (INGREDIENTS):\u003c\/strong\u003e\u003cbr\u003eImidocarb dipropionate (equivalent to 85 mg\/ml Imidocarb) 121.15 mg\/ml\u003c\/span\u003e\u003cbr\u003e\u003cbr\u003e\u003cspan\u003e\u003cstrong\u003eINDICATIONS: For the treatment and prophylaxis of \u003c\/strong\u003e \u003cem\u003eBabesia canis\u003c\/em\u003e  and \u003cem\u003eEhrlichia spp.\u003c\/em\u003e\u003cbr\u003einfestations in dogs .\u003cem\u003e\u003c\/em\u003e\u003cem\u003e\u003c\/em\u003e\u003c\/span\u003e\u003cbr\u003e\u003cbr\u003e\u003cspan\u003e\u003cstrong\u003eCONTRAINDICATIONS:\u003c\/strong\u003e\u003c\/span\u003e\u003cspan\u003e\u003cbr\u003eImizol is not administered intravenously.  \u003c\/span\u003e\u003cspan\u003eIt should not be administered in case of hypersensitivity to the active substance or excipients.\u003c\/span\u003e\u003cspan\u003e\u003cbr\u003e\u003cbr\u003e\u003cstrong\u003eADVERSE REACTIONS:\u003c\/strong\u003e\u003c\/span\u003e\u003cspan\u003e\u003cbr\u003eAfter treatment, parasympathetic symptoms may appear in some animals (sialorrhea, vomiting, general weakness), these symptoms can be alleviated by administering atropine sulfate.  \u003c\/span\u003e\u003cspan\u003eDeaths have been recorded as a result of anaphylactic reaction. \u003c\/span\u003e\u003cbr\u003e\u003cspan\u003eCommonly observed adverse reactions are: pain during injection and mild cholinergic signs such as salivation, nasal discharge or short episodes of vomiting. Other less commonly observed effects are dyspnoea, agitation, diarrhoea and mild inflammation at the inoculation site which may last from a few days to a month. Ulceration at the injection site is rare.  \u003c\/span\u003e\u003cspan\u003eIf you notice any serious reactions or other effects not mentioned in this leaflet, please  \u003c\/span\u003e\u003cspan\u003einform your veterinary surgeon.\u003c\/span\u003e\u003cbr\u003e\u003cspan\u003eThe frequency of adverse reactions is defined using the following convention:\u003c\/span\u003e\u003cbr\u003e\u003cspan\u003e- Very common (more than 1 in 10 animals treated displaying adverse reactions);\u003c\/span\u003e\u003cbr\u003e\u003cspan\u003e- Common (more than 1 but less than 10 animals in 100 animals treated);\u003c\/span\u003e\u003cbr\u003e\u003cspan\u003e- Uncommon (more than 1 but less than 10 animals in 1,000 animals treated);\u003c\/span\u003e\u003cbr\u003e\u003cspan\u003e- Rare (more than 1 but less than 10 animals in 10,000 animals treated);\u003c\/span\u003e\u003cbr\u003e\u003cspan\u003e- Very rare (less than 1 animal in 10,000 animals treated, including isolated reports).\u003c\/span\u003e\u003cbr\u003e\u003cbr\u003e\u003cspan\u003e\u003cstrong\u003eTARGET SPECIES:\u003c\/strong\u003e\u003cbr\u003eDogs.\u003c\/span\u003e\u003cspan\u003e\u003cbr\u003e\u003cbr\u003e\u003cstrong\u003eDOSAGE FOR EACH SPECIES, ROUTE(S) AND METHOD OF ADMINISTRATION:\u003c\/strong\u003e\u003c\/span\u003e\u003cspan\u003e\u003cbr\u003eAdminister subcutaneously or intramuscularly, the subcutaneous route being preferred.\u003c\/span\u003e\u003cbr\u003e\u003cspan\u003eIn some cases, preventive treatment against babesiosis may be justified. A single treatment - depending on the severity of the infection - provides protection for a period of approximately one month.\u003cbr\u003e\u003cstrong\u003eDogs:\u003c\/strong\u003e\u003cbr\u003e\u003cem\u003eBabesiosis:\u003c\/em\u003e - treatment ( 0.25-0.5 ml product\/10 kg body weight);\u003cbr\u003e                 - prophylaxis ( 0.25 ml product\/10 kg body weight).\u003cbr\u003e\u003cem\u003eEhrlichiosis:\u003c\/em\u003e - treatment ( 0.5 ml product\/10 kg body weight)\u003cbr\u003eConcomitant treatment of \u003cem\u003eBabesiosis\/Ehrlichiosis: \u003c\/em\u003e0.5 ml product\/10 kg body weight.\u003c\/span\u003e\u003cbr\u003e\u003cbr\u003e\u003cspan\u003e\u003c\/span\u003e\u003cspan\u003e\u003c\/span\u003e\u003cspan\u003e\u003cstrong\u003eRECOMMENDATIONS ON CORRECT ADMINISTRATION:\u003c\/strong\u003e\u003c\/span\u003e\u003cspan\u003e\u003cbr\u003eTo ensure correct dosing, body weight should be determined as accurately as possible.  \u003c\/span\u003e\u003cspan\u003eIn dogs with functional disorders of the lungs, liver or kidneys, it should only be used in accordance with the benefit\/ risk assessment of the veterinarian.\u003c\/span\u003e\u003cspan\u003e\u003cbr\u003e\u003cbr\u003e\u003cstrong\u003eWITHDRAWAL PERIOD:\u003c\/strong\u003e \u003cbr\u003eNot applicable.\u003c\/span\u003e\u003cbr\u003e\u003cbr\u003e\u003cspan\u003e\u003cstrong\u003eSPECIAL STORAGE PRECAUTIONS:\u003c\/strong\u003e\u003c\/span\u003e\u003cbr\u003e\u003cspan\u003eKeep out of the reach of children.\u003c\/span\u003e\u003cbr\u003e\u003cspan\u003eDo not store above 25 \u003csup\u003e0\u003c\/sup\u003e C.\u003c\/span\u003e\u003cbr\u003e\u003cspan\u003eProtect from freezing. Protect\u003c\/span\u003e\u003cspan\u003e\u003cbr\u003efrom light.\u003c\/span\u003e\u003cbr\u003e\u003cspan\u003eShelf life after first opening the immediate packaging: 28 days.\u003c\/span\u003e\u003cspan\u003e\u003c\/span\u003e\u003cspan\u003e\u003cbr\u003e\u003cbr\u003e\u003cstrong\u003eSPECIAL WARNING(S):\u003c\/strong\u003e\u003c\/span\u003e\u003cu\u003e\u003cspan\u003e\u003cbr\u003eSpecial warnings for each target species:\u003c\/span\u003e\u003c\/u\u003e\u003cspan\u003e\u003cbr\u003eNone.\u003c\/span\u003e\u003cbr\u003e\u003cu\u003e\u003cspan\u003eSpecial precautions for use in animals:\u003c\/span\u003e\u003c\/u\u003e\u003cbr\u003e\u003cspan\u003eNone.\u003c\/span\u003e\u003cbr\u003e\u003cu\u003e\u003cspan\u003eSpecial precautions to be taken by the person administering the veterinary medicinal product to animals:\u003c\/span\u003e\u003c\/u\u003e\u003cspan\u003e\u003cbr\u003eDo not use in people with known hypersensitivity to the active substance.  \u003c\/span\u003e\u003cspan\u003eIn case of accidental contact with the skin or eyes, rinse thoroughly with water.  \u003c\/span\u003e\u003cspan\u003ePersonal protective equipment consisting of impervious gloves should be worn when handling the veterinary medicinal product.  \u003c\/span\u003e\u003cspan\u003eSeek medical advice immediately if adverse reactions such as signs of anti-cholinesterase activity occur.  \u003c\/span\u003e\u003cspan\u003eIn case of accidental injection of this product, seek medical advice immediately and show the package leaflet to the doctor, even if only a small amount of the product has been injected.  \u003c\/span\u003e\u003cspan\u003eDo not use in people with known hypersensitivity to the active substance or to substances with anticholinesterase activity.  \u003c\/span\u003e\u003cspan\u003eAccidentally contaminated skin or eyes should be washed immediately with water.  \u003c\/span\u003e\u003cspan\u003eAppropriate protective equipment (impervious gloves) should be worn.  \u003c\/span\u003e\u003cspan\u003eIn case of accidental contact or the appearance of anticholinesterase-type signs, seek medical advice immediately.\u003c\/span\u003e\u003cbr\u003e\u003cu\u003e\u003cspan\u003eUse during pregnancy and lactation:\u003c\/span\u003e\u003c\/u\u003e\u003cbr\u003e\u003cspan\u003eLaboratory studies conducted on target species have not demonstrated the harmlessness of the product during lactation.  \u003c\/span\u003e\u003cspan\u003eThe safety and efficacy of imidocarb have not been determined in puppies, breeding dogs, during lactation or in pregnant animals.  \u003c\/span\u003e\u003cspan\u003eIt should be used based on the benefit\/risk assessment carried out by the responsible veterinarian.\u003c\/span\u003e\u003cbr\u003e\u003cu\u003e\u003cspan\u003eInteractions with other medicinal products or other forms of interaction:\u003c\/span\u003e\u003c\/u\u003e\u003cbr\u003e\u003cspan\u003eDo not administer concomitantly with cholinesterase inhibitors. Do not administer concomitantly with compounds that may exhibit anticholinesterase activity.\u003c\/span\u003e\u003cbr\u003e\u003cu\u003e\u003cspan\u003eOverdose (symptoms, emergency procedures, antidotes), as appropriate:\u003c\/span\u003e\u003c\/u\u003e\u003cbr\u003e\u003cspan\u003eIn the case of administration of a dose 1.75 times higher than the recommended therapeutic dose, symptoms suggestive of a cholinergic effect occur, the antidote being atropine sulfate. Loss of life has been observed following administration of five times the recommended dose.\u003c\/span\u003e\u003cbr\u003e\u003cu\u003e\u003cspan\u003eIncompatibilities:\u003c\/span\u003e\u003c\/u\u003e\u003cbr\u003e\u003cspan\u003eIn the absence of compatibility studies, this veterinary medicinal product must not be mixed with other veterinary medicinal products.\u003c\/span\u003e\u003cbr\u003e\u003cbr\u003e\u003cstrong\u003e\u003cspan\u003eSPECIAL PRECAUTIONS FOR THE DISPOSAL OF UNUSED PRODUCT OR WASTE MATERIALS, IF ANY:\u003c\/span\u003e\u003c\/strong\u003e\u003cbr\u003e\u003cspan\u003eMedicinal products should not be disposed of via wastewater or household waste. \u003c\/span\u003e\u003cspan\u003eAsk your veterinarian how to dispose of medicines no longer required. This will help protect the environment.\u003cbr\u003e\u003cbr\u003e\u003cstrong\u003eSIZE:\u003c\/strong\u003e\u003c\/span\u003e\u003cbr\u003e\u003cspan\u003eBottle x 40 ml\u003c\/span\u003e\u003cspan\u003e\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product_section product_section_specs\"\u003e\n\u003cdiv class=\"product_section_link\"\u003e\n\u003cdiv class=\"link _mPS2id-t mPS2id-target mPS2id-target-first mPS2id-target-last\" id=\"specificatii-produs\"\u003e\u003c\/div\u003e\n\u003cdiv class=\"data\" data-icon=\"description\" data-id=\"specificatii-produs\" data-title=\"Specificatii\"\u003e\u003cbr\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product_section_title\"\u003e\n\u003cdiv class=\"__i\"\u003e\n\u003cdiv class=\"icon\"\u003e\u003cbr\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product_section_content\"\u003e\n\u003cdiv class=\"__i\"\u003e\n\u003cdiv class=\"specs_table\"\u003e\u003cspan\u003e\u003cstrong\u003eANTIPARASSITARIO INTERNO PER CANI IMIZOL 40ML \u003c\/strong\u003e \u003cbr\u003e\u003cbr\u003e\u003cstrong\u003eImizol Ro, soluzione iniettabile da 85 mg\/ml\u003c\/strong\u003e per cani.\u003cbr\u003e\u003cbr\u003e\u003cstrong\u003eINDICAZIONE DEI PRINCIPI ATTIVI E DEGLI ALTRI INGREDIENTI:\u003c\/strong\u003e\u003cbr\u003eImidocarb dipropionato (equivalente a 85 mg\/ml Imidocarb) 121,15 mg\/ml\u003cbr\u003e\u003cbr\u003e\u003cstrong\u003eINDICAZIONI:\u003c\/strong\u003e \u003cbr\u003ePer il trattamento e la profilassi delle infestazioni da \u003cem\u003eBabesia canis\u003c\/em\u003e  ed \u003cem\u003eEhrlichia spp nei cani.\u003c\/em\u003e\u003cbr\u003e\u003cbr\u003e\u003cstrong\u003eCONTROINDICAZIONI:\u003c\/strong\u003e\u003cbr\u003eImizol non viene somministrato per via endovenosa.  Non verrà somministrato in caso di ipersensibilità al principio attivo o agli eccipienti.\u003cbr\u003e\u003cbr\u003e\u003cstrong\u003eREAZIONI AVVERSE:\u003c\/strong\u003e\u003cbr\u003eSintomi parasimpatici (scialorrea, vomito, debolezza generale) possono comparire dopo il trattamento in alcuni animali; questi sintomi possono essere alleviati dalla somministrazione di atropina solfato.  Sono stati registrati decessi a seguito della reazione anafilattica. \u003cbr\u003eGli effetti avversi comunemente osservati sono: dolore durante l'iniezione e lievi segni colinergici come salivazione, naso che cola o brevi episodi di vomito. Altri effetti meno comunemente osservati sono dispnea, agitazione, diarrea e lieve infiammazione nel sito di inoculazione che può durare da pochi giorni a un mese. Raramente si verificano ulcerazioni nel sito di iniezione.  Se notate reazioni gravi o altri effetti non menzionati in questo foglio illustrativo,  informate il vostro veterinario.\u003cbr\u003eLa frequenza delle reazioni avverse è definita utilizzando la seguente convenzione:\u003cbr\u003e- Molto comune (più di 1 su 10 animali trattati mostra reazioni avverse);\u003cbr\u003e- Frequenti (più di 1 ma meno di 10 animali su 100 animali trattati);\u003cbr\u003e- Non comune (più di 1 ma meno di 10 animali su 1.000 animali trattati);\u003cbr\u003e- Rari (più di 1 ma meno di 10 animali su 10.000 animali trattati);\u003cbr\u003e- Molto raro (meno di 1 animale su 10.000 animali trattati, comprese segnalazioni isolate).\u003cbr\u003e\u003cbr\u003e\u003cstrong\u003eSPECIE DI DESTINAZIONE:\u003c\/strong\u003e\u003cbr\u003eCani.\u003cbr\u003e\u003cbr\u003e\u003cstrong\u003ePOSOLOGIA PER CIASCUNA SPECIE, VIA DI SOMMINISTRAZIONE E MODALITÀ DI SOMMINISTRAZIONE:\u003c\/strong\u003e\u003cbr\u003eViene somministrato per via sottocutanea o intramuscolare, essendo preferibile la via sottocutanea.\u003cbr\u003eIn alcuni casi può essere giustificato un trattamento preventivo contro la babesiosi. Un singolo trattamento, a seconda della gravità dell'infezione, fornisce protezione per un periodo di circa un mese.\u003cbr\u003e\u003cstrong\u003eCani:\u003c\/strong\u003e\u003cbr\u003e\u003cem\u003eBabesiosi:\u003c\/em\u003e - trattamento ( 0,25-0,5 ml di prodotto\/10 kg di peso corporeo);\u003cbr\u003e                 - profilassi ( 0,25 ml di prodotto\/10 kg di peso corporeo).\u003cbr\u003e\u003cem\u003eEhrlichiosi:\u003c\/em\u003e - trattamento ( 0,5 ml di prodotto\/10 kg di peso corporeo)\u003cbr\u003eTrattamento simultaneo di \u003cem\u003eBabesiosi\/Ehrlichiosi: \u003c\/em\u003e0,5 ml di prodotto\/10 kg di peso corporeo.\u003cbr\u003e\u003cbr\u003e\u003cstrong\u003eRACCOMANDAZIONI RIGUARDO LA CORRETTA SOMMINISTRAZIONE:\u003c\/strong\u003e\u003cbr\u003ePer garantire un dosaggio corretto, il peso corporeo deve essere determinato nel modo più accurato possibile.  Nei cani con disturbi funzionali dei polmoni, del fegato o dei reni, sarà utilizzato solo in conformità con la valutazione del rapporto rischio\/beneficio del veterinario.\u003cbr\u003e\u003cbr\u003e\u003cstrong\u003eTEMPO DI ATTESA:\u003c\/strong\u003e \u003cbr\u003eNon applicabile.\u003cbr\u003e\u003cbr\u003e\u003cstrong\u003ePRECAUZIONI PARTICOLARI PER LA CONSERVAZIONE:\u003c\/strong\u003e\u003cbr\u003eTenere fuori dalla portata dei bambini.\u003cbr\u003eNon conservare a temperature superiori a 25 \u003csup\u003e0\u003c\/sup\u003e C.\u003cbr\u003eEvitare il congelamento.\u003cbr\u003eProteggere dalla luce.\u003cbr\u003ePeriodo di validità dopo la prima apertura dell'imballaggio primario: 28 giorni.\u003cbr\u003e\u003cbr\u003e\u003cstrong\u003eAVVERTENZA(E) SPECIALE(I):\u003c\/strong\u003e\u003cu\u003e\u003cbr\u003eAvvertenze speciali per ciascuna specie di destinazione:\u003c\/u\u003e\u003cbr\u003eNessuna.\u003cbr\u003e\u003cu\u003ePrecauzioni speciali per l'impiego negli animali:\u003c\/u\u003e\u003cbr\u003eNessuna.\u003cbr\u003e\u003cu\u003ePrecauzioni speciali che devono essere adottate dalla persona che somministra il medicinale veterinario agli animali:\u003c\/u\u003e\u003cbr\u003eNon utilizzare da parte di persone con nota ipersensibilità al principio attivo.  In caso di contatto accidentale con la pelle o gli occhi lavare abbondantemente con acqua.  Durante la manipolazione del medicinale veterinario è necessario indossare dispositivi di protezione individuale costituiti da guanti impermeabili.  Rivolgersi immediatamente al medico se si verificano effetti collaterali come segni di attività anticolinesterasica.  In caso di iniezione accidentale di questo prodotto, consultare immediatamente un medico e mostrare il foglietto illustrativo del prodotto, anche se è stata iniettata una piccola quantità di prodotto.  Da non utilizzare da persone note per essere ipersensibili al principio attivo o a sostanze ad azione anticolinesterasica.  Le aree della pelle o degli occhi contaminate accidentalmente devono essere lavate immediatamente con acqua.  Verranno indossati adeguati dispositivi di protezione (guanti impermeabili).  In caso di contatto accidentale o comparsa di segni di tipo anticolinesterasici, consultare immediatamente il medico.\u003cbr\u003e\u003cu\u003eImpiego durante la gravidanza e l'allattamento:\u003c\/u\u003e\u003cbr\u003eStudi di laboratorio effettuati sulla specie di destinazione non hanno dimostrato l'innocuità del prodotto durante l'allattamento.  La sicurezza e l'efficacia dell'imidocarb non sono state determinate nei cuccioli, nei cani riproduttori, negli animali in allattamento o in gravidanza.  Verrà utilizzato in base alla valutazione del rapporto beneficio\/rischio da parte del veterinario responsabile.\u003cbr\u003e\u003cu\u003eInterazioni con altri medicinali veterinari o altre forme d'interazione:\u003c\/u\u003e\u003cbr\u003eNon somministrare contemporaneamente agli inibitori della colinesterasi. Non somministrare in concomitanza con farmaci che possono manifestare attività anticolinesterasica.\u003cbr\u003e\u003cu\u003eSovradosaggio (sintomi, procedure d'emergenza, antidoti), a seconda dei casi:\u003c\/u\u003e\u003cbr\u003eIn caso di somministrazione di una dose 1,75 volte superiore alla dose terapeutica raccomandata, compaiono sintomi che si riferiscono ad un effetto colinergico, l'antidoto è atropina solfato. È stata osservata perdita di vite umane in seguito alla somministrazione di una quantità cinque volte superiore alla dose indicata.\u003cbr\u003e\u003cu\u003eIncompatibilità:\u003c\/u\u003e\u003cbr\u003eIn assenza di studi di compatibilità, questo medicinale veterinario non deve essere miscelato con altri medicinali veterinari.\u003cbr\u003e\u003cbr\u003e\u003cstrong\u003ePRECAUZIONI SPECIALI PER LO SMALTIMENTO DEL PRODOTTO NON UTILIZZATO O DEI RIFIUTI, COME APPLICABILE:\u003c\/strong\u003e\u003cbr\u003eI medicinali non devono essere smaltiti nelle acque reflue o nei rifiuti domestici. Chiedi al tuo veterinario informazioni su come smaltire i farmaci che non servono più. Queste misure contribuiscono alla protezione dell’ambiente.\u003cbr\u003e\u003cbr\u003e\u003cstrong\u003eFORMATO:\u003c\/strong\u003e\u003cbr\u003eBottiglia x 40 ml\u003c\/span\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e","brand":"MSD Animal Heath","offers":[{"title":"Default Title","offer_id":49862113657179,"sku":"","price":79.99,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0476\/3261\/3543\/files\/859875_product.jpg?v=1736431480","url":"https:\/\/www.petshopluna.com\/it\/products\/imizol-ro-85mg-ml-40ml-internal-antiparasite-for-dogs-imidocarb-babesia-canis-ehrlichia-spp","provider":"Pet Shop Maya","version":"1.0","type":"link"}